Profili concorrenziali e regolatori alla luce del caso Avastin/Lucentis
Competitive and regulatory issues emerging from the Avastin/Lucentis
Abstract: Competitive and regulatory issues emerging from the Avastin/Lucentis case
The present essay provides a vide overview of the issues at stake in the recent case Avastin/Lucentis. The paper starts from the Court reasoning and underlines the main aspects connected to the competition in the medicinal products market. The analysis describes the interactions between national and EU competition authorities. The attempt is to understand and anticipate the market and regulatory concerns that will be considered by the Consiglio di Stato.
Keywords: Healthcare; EU internal market; Competition; Competition authorities, Avastin, Lucentis
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.